KATHRYN KLOSS: Open Payments
NPI 1063715092 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,123 in 179 payments from 23 companies in 2025. Trend: 2023 $12,917 · 2024 $5,643 · 2025 $4,123
Food & beverage: $4,123
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 28 | $765 |
| Alkermes, Inc. | 12 | $325 |
| Axsome Therapeutics, Inc. | 13 | $319 |
| Noven Therapeutics, LLC | 13 | $259 |
| Teva Pharmaceuticals USA, Inc. | 11 | $247 |
| Neurocrine BioSciences, Inc. | 12 | $236 |
| Otsuka America Pharmaceutical, Inc. | 15 | $235 |
| E.R. Squibb & Sons, L.L.C. | 7 | $225 |
| Corium, LLC | 9 | $215 |
| ABBVIE INC. | 12 | $195 |
Products named: CAPLYTA, REXULTI, Xelstrym, Sunosi, INGREZZA, AUSTEDO XR, COBENFY, Azstarys.
Industry payments across FL — which companies pay providers there.
